Though there is no statistical association between PD-L1 expression and the prognosis of NPC patients, all 5 patients with low PD-L1 expression were alive without local recurrent evidence after 37–61 months of follow-up. This evidence concerns the gene CD274 and nasopharyngeal carcinoma.